[go: up one dir, main page]

WO2003055528A3 - Composes amphiphiles a usage pharmaceutique ou cosmetique - Google Patents

Composes amphiphiles a usage pharmaceutique ou cosmetique Download PDF

Info

Publication number
WO2003055528A3
WO2003055528A3 PCT/FR2002/004561 FR0204561W WO03055528A3 WO 2003055528 A3 WO2003055528 A3 WO 2003055528A3 FR 0204561 W FR0204561 W FR 0204561W WO 03055528 A3 WO03055528 A3 WO 03055528A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical
cosmetic use
amphiphilic compounds
molecules
cosmetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2002/004561
Other languages
English (en)
Other versions
WO2003055528A2 (fr
Inventor
Nicolas Calvet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Physica Sarl
Original Assignee
Physica Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Physica Sarl filed Critical Physica Sarl
Priority to AU2002364684A priority Critical patent/AU2002364684A1/en
Priority to EP02805808A priority patent/EP1458415A2/fr
Priority to US10/499,542 priority patent/US20050069513A1/en
Priority to CA002472124A priority patent/CA2472124A1/fr
Publication of WO2003055528A2 publication Critical patent/WO2003055528A2/fr
Publication of WO2003055528A3 publication Critical patent/WO2003055528A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

L’invention concerne des composés amphiphiles, à usage pharmaceutique ou cosmétique, constitués d’un complexe de paire d’ions entre un acyl aminoacide et une molécule biologiquement active. Lesdits composés formés permettent d’améliorer les propriétés des molécules pharmaceutiques ou cosmétiques en particulier des petites molécules organiques, des peptides et des protéines, des nucléotides ou des gènes.
PCT/FR2002/004561 2001-12-27 2002-12-24 Composes amphiphiles a usage pharmaceutique ou cosmetique Ceased WO2003055528A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU2002364684A AU2002364684A1 (en) 2001-12-27 2002-12-24 Amphiphilic compounds for pharmaceutical or cosmetic use
EP02805808A EP1458415A2 (fr) 2001-12-27 2002-12-24 Composes amphiphiles a usage pharmaceutique ou cosmetique
US10/499,542 US20050069513A1 (en) 2001-12-27 2002-12-24 Amphiphilic compounds for pharmaceutical or cosmetic use
CA002472124A CA2472124A1 (fr) 2001-12-27 2002-12-24 Composes amphiphiles a usage pharmaceutique ou cosmetique

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR01/16936 2001-12-27
FR0116936A FR2834215B1 (fr) 2001-12-27 2001-12-27 Composes amphiphiles a usage pharmaceutique ou cosmetique

Publications (2)

Publication Number Publication Date
WO2003055528A2 WO2003055528A2 (fr) 2003-07-10
WO2003055528A3 true WO2003055528A3 (fr) 2004-02-26

Family

ID=8871028

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2002/004561 Ceased WO2003055528A2 (fr) 2001-12-27 2002-12-24 Composes amphiphiles a usage pharmaceutique ou cosmetique

Country Status (6)

Country Link
US (1) US20050069513A1 (fr)
EP (1) EP1458415A2 (fr)
AU (1) AU2002364684A1 (fr)
CA (1) CA2472124A1 (fr)
FR (1) FR2834215B1 (fr)
WO (1) WO2003055528A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2959936B1 (fr) * 2010-05-14 2012-08-03 Physica Pharma Composition nasales a visee systemique a base de cocoyl proline ou d 'au moins un de ses constituants
FR2971943B1 (fr) 2011-02-24 2013-08-02 Physica Pharma Compositions pharmaceutiques a action locale administrables par application cutanee
FR2971941B1 (fr) 2011-02-24 2013-08-02 Physica Pharma Compositions pharmaceutiques administrables par voie cutanee et destinees au traitement local de la dermatite atopique canine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5853755A (en) * 1993-07-28 1998-12-29 Pharmaderm Laboratories Ltd. Biphasic multilamellar lipid vesicles
WO2001035998A1 (fr) * 1999-11-12 2001-05-25 Pharmaderm Laboratories, Ltd. Compositions pour administration transdermique et transmuqueuse d'agents therapeutiques

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US442090A (en) * 1890-12-02 Edwin t
DE2111361B2 (de) * 1971-03-10 1973-02-15 Verwendung von n-acylaminosaeuren, deren salzen und/oder estern als emulgatoren
FR2289179A1 (fr) * 1974-10-28 1976-05-28 Morelle Jean Sels metalliques de lipoaminoacides
US4837026A (en) * 1985-10-03 1989-06-06 Rajakhyaksha Vithal J Transdermal and systemic preparation and method
JP3202777B2 (ja) * 1992-01-24 2001-08-27 リンテック株式会社 経皮吸収促進剤及びテープ製剤
US5952004A (en) * 1994-03-18 1999-09-14 Shire Laboratories Inc. Emulsified drug delivery systems
FR2828102B1 (fr) * 2001-03-28 2004-07-09 Ifc Sa Utilisation des lipoaminoacides dans une composition pharmaceutique comme promoteur et systeme disperse a usage pharmaceutique contenant de tels composes

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5853755A (en) * 1993-07-28 1998-12-29 Pharmaderm Laboratories Ltd. Biphasic multilamellar lipid vesicles
WO2001035998A1 (fr) * 1999-11-12 2001-05-25 Pharmaderm Laboratories, Ltd. Compositions pour administration transdermique et transmuqueuse d'agents therapeutiques

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
GULATI MONICA ET AL: "Lipophilic drug derivatives in liposomes.", INTERNATIONAL JOURNAL OF PHARMACEUTICS (AMSTERDAM), vol. 165, no. 2, 14 May 1998 (1998-05-14), pages 129 - 168, XP002214801, ISSN: 0378-5173 *
NASH R A ET AL: "The possibility of lidocaine ion pair absorption through excised hairless mouse skin.", SKIN PHARMACOLOGY: THE OFFICIAL JOURNAL OF THE SKIN PHARMACOLOGY SOCIETY. SWITZERLAND 1992, vol. 5, no. 3, 1992, pages 160 - 170, XP002044700, ISSN: 1011-0283 *
TONDRE C ET AL: "Properties of the amphiphilic films in mixed cationic/anionic vesicles: a comprehensive view from a literature analysis.", ADVANCES IN COLLOID AND INTERFACE SCIENCE. NETHERLANDS 8 OCT 2001, vol. 93, no. 1-3, 8 October 2001 (2001-10-08), pages 115 - 134, XP002214799, ISSN: 0001-8686 *
VALENTA C ET AL: "The dermal delivery of lignocaine: Influence of ion pairing.", INTERNATIONAL JOURNAL OF PHARMACEUTICS (KIDLINGTON)., vol. 197, no. 1-2, 20 March 2000 (2000-03-20), pages 77 - 85, XP002214800, ISSN: 0378-5173 *
WOO G T ET AL: "EMULSIONS PREPARED BY INTERFACIAL ION PAIR FORMATIONS BETWEEN AMINO ACIDS AND FATTY ACIDS", JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 76, no. 11, 1987, pages S306, XP002214798, ISSN: 0022-3549 *

Also Published As

Publication number Publication date
FR2834215A1 (fr) 2003-07-04
AU2002364684A1 (en) 2003-07-15
WO2003055528A2 (fr) 2003-07-10
FR2834215B1 (fr) 2004-07-16
EP1458415A2 (fr) 2004-09-22
US20050069513A1 (en) 2005-03-31
CA2472124A1 (fr) 2003-07-10

Similar Documents

Publication Publication Date Title
WO2005003296A3 (fr) Proteines hybrides d'albumine
WO2002014485A3 (fr) Nouveau gene kallikreine
WO2003055528A3 (fr) Composes amphiphiles a usage pharmaceutique ou cosmetique
WO2003092736A3 (fr) Conjugues comportant des acides nucleiques peptidiques
WO2006122971A3 (fr) Traitement de maladies a l'aide d'un systeme d'expression regulee, ameliore
AU2002239444A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
AU2002256019A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
AU2002258617A1 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
AU2002356494A1 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
AU2002250346A1 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
AU2002254438A1 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
AU2001257287A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2003040357A3 (fr) Genes codant des proteines phosphoenolpyruvate-sucre phototransferase
WO2002018554A3 (fr) Proteines humaines isolees de metabolisation de medicaments, molecules d'acides nucleiques et utilisations associees
AU2002223183A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
AU2001292687A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
AU2001289134A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
AU2001288688A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
AU2002258618A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
AU2002257016A1 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
AU2002240295A1 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
AU2002227336A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
AU2002230711A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
AU2001264969A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
AU2002256547A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2002805808

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2472124

Country of ref document: CA

WWP Wipo information: published in national office

Ref document number: 2002805808

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10499542

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP